Vectibix Prescribing Information. Thousand Oaks, CA: Amgen, Inc.; June 2024. Available at Accessed Aug. 2. National
Product Monograph: Vectibix (Panitumumab). Amgen Canada, Octo. Vectibix (Panitumumab) Prescribing Information. Amgen USA, August 2024. Kang P
These highlights do not include all the information needed to use Vectibix safely and effectively. See full prescribing information for Vectibix. Vectibix (panitumumab) Injection for Intravenous Use . Initial US Approval: 2024 . WARNING: DERMATOLOGIC TOXICITY and INFUSION . REACTIONS . See full prescribing information for complete boxed
The FDA has approved prescribing information changes to the indication and usage section of the labels for Erbitux and Vectibix.
Vectibix (panitumumab). Full prescribing information/FDA labeling. pi.amgen.com/united_states/vectibix/vectibix_pi.pdf. Last accessed May
Vectibix (panitumumab) [prescribing information]. Mississauga, Ontario, Canada: Amgen Canada Inc; March 2024. Topic Version 121.0.
321 Panitumumab (Vectibix) Medicaid. 4Q 2024 annual review per updated prescribing information; references reviewed and updated.
Use of these documents is the responsibility of the prescribing clinician and is information/vectibix-epar-product-information_en.pdf. 9.
To see the Vectibix Prescribing Information, including Boxed Warning visit www.vectibix.com. About Colorectal Cancer. Colorectal cancer is
Comments
SHOULD BE:
Andy had literally simply RELAYED all the various information.